PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-26 (1)

Date Title Company
26-Feb-2026 FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis Businesswire